Kyle Gano is CEO at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 31 open-market trades across 1 company since 2013, most recently 2026-09-11.
CIK 0001567160
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 31 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBIX | 154,728 | $21.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL | 2026-01-16 | 2026-01-20 | $132.70 | $4.8M | +0.5% | -3.9% | -2.7% |
| NBIX | SELL · 10b5-1 | 2025-11-04 | 2025-11-04 | $141.97 | $43K | -1.9% | +4.4% | -6.8% |
| NBIX | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $116.85 | $598K | +2.2% | -3.1% | +4.6% |
| NBIX | SELL · 10b5-1 | 2025-02-10 | 2025-02-12 | $118.39 | $232K | -1.2% | -5.6% | -0.4% |
| NBIX | SELL · 10b5-1 | 2025-01-31 | 2025-02-04 | $152.87 | $471K | -24.2% | -25.7% | -27.6% |
| NBIX | SELL · 10b5-1 | 2025-01-15 | 2025-01-17 | $141.50 | $9.2M | +6.0% | -21.2% | -29.9% |
| NBIX | SELL · 10b5-1 | 2024-02-13 | 2024-02-15 | $132.89 | $359K | +0.4% | +3.9% | +5.9% |
| NBIX | SELL · 10b5-1 | 2024-02-06 | 2024-02-08 | $140.32 | $587K | -3.0% | +2.9% | +3.2% |
| NBIX | SELL · 10b5-1 | 2024-01-31 | 2024-02-02 | $140.70 | $434K | -6.7% | -5.7% | -1.0% |
| NBIX | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $131.47 | $19.7M | +3.3% | +6.7% | +3.6% |
| NBIX | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $107.41 | $458K | +2.1% | +5.6% | +1.8% |
| NBIX | SELL | 2023-02-06 | 2023-02-08 | $102.65 | $3.3M | -2.5% | -8.5% | -7.2% |
| NBIX | SELL | 2023-01-31 | 2023-02-02 | $109.98 | $339K | -5.8% | -7.8% | -9.8% |
| NBIX | SELL | 2022-02-07 | 2022-02-09 | $80.59 | $980K | +10.7% | +12.7% | +3.8% |
| NBIX | SELL | 2022-01-05 | 2022-01-07 | $85.50 | $2.4M | -2.6% | +8.4% | +31.7% |
| NBIX | SELL | 2021-02-05 | 2021-02-09 | $115.55 | $1.4M | -4.3% | -18.5% | -21.3% |
| NBIX | SELL | 2020-11-12 | 2020-11-16 | $90.73 | $410K | +3.1% | +6.5% | +21.3% |
| NBIX | SELL | 2020-08-05 | 2020-08-07 | $118.87 | $537K | -1.6% | -4.5% | -12.7% |
| NBIX | SELL | 2020-04-24 | 2020-04-28 | $99.47 | $385K | +9.0% | +19.8% | +25.5% |
| NBIX | SELL | 2020-02-07 | 2020-02-11 | $103.33 | $335K | -9.5% | -24.4% | +6.0% |
| NBIX | SELL | 2020-02-05 | 2020-02-07 | $102.86 | $862K | -0.4% | -14.6% | +5.2% |
| NBIX | SELL | 2019-02-06 | 2019-02-08 | $83.56 | $127K | -8.8% | -5.6% | -7.0% |
| NBIX | SELL | 2019-02-05 | 2019-02-06 | $88.14 | $174K | -3.2% | -8.0% | -6.5% |
| NBIX | SELL | 2019-02-04 | 2019-02-06 | $88.12 | $557K | -3.2% | -8.0% | -6.5% |
| NBIX | SELL | 2019-02-04 | 2019-02-06 | $88.14 | $121K | -3.2% | -8.0% | -6.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.